Insulin Glargine (U-100) Cartridge Systems and Pens and Paclitaxel Concentrate Injection
Determining the interaction of Insulin Glargine (U-100) Cartridge Systems and Pens and Paclitaxel Concentrate Injection and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin glargine
Brand name: Basaglar KwikPen, Lantus, Lantus Solostar Pen, Toujeo SoloStar, Lantus OptiClik Cartridge, Toujeo Max SoloStar, Lantus SoloStar
Synonyms: Insulin glargine, Insulin Glargine
Generic Name: paclitaxel
Brand name: Onxol, Taxol
Synonyms: Paclitaxel, PACLitaxel (Conventional)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin Glargine (U-100) Cartridge Systems and Pens-Paclitaxel Intravenous
- Insulin Glargine (U-100) Cartridge Systems and Pens-Paclitaxel Novaplus
- Insulin Glargine (U-100) Cartridge Systems and Pens-Paclitaxel protein-bound
- Insulin Glargine (U-100) Cartridge Systems and Pens-Paclitaxel protein-bound Intravenous
- Insulin Glargine (U-100) Cartridge Systems and Pens-Pacnex
- Insulin Glargine (U-100) Cartridge Systems and Pens-Pacnex LP
- Paclitaxel Concentrate Injection-Insulin Glargine (U-100) Vials
- Paclitaxel Concentrate Injection-Insulin Glargine (U-300) Pens
- Paclitaxel Concentrate Injection-Insulin glargine and lixisenatide
- Paclitaxel Concentrate Injection-Insulin glargine and lixisenatide Subcutaneous
- Paclitaxel Concentrate Injection-Insulin glargine, recombinant Subcutaneous
- Paclitaxel Concentrate Injection-Insulin glulisine